Table 1.
Baseline clinical and physical characteristics as mean ± SD with significance (P) of the 36 patients their treatments
| Baseline characteristics | Patients with end-stage renal disease |
|||
|---|---|---|---|---|
| Stable (n = 12) | Asymptomatic (n = 12) | Unstable (n = 12) | P-value | |
| Gender, female (%) | 25.0 | 33.3 | 66.7 | 0.091 |
| Age (years) | 72 ± 16 | 72 ± 10 | 70 ± 16 | 0.957 |
| Height (cm) | 173.3 ± 7.4 | 172.1 ± 8.7 | 167.1 ± 5.1 | 0.094 |
| Weight (kg) | 77.8 ± 10.6 | 78.6 ± 16.0 | 72.6 ± 18.1 | 0.589 |
| BMI (kg/m2) | 26.0 ± 4.1 | 27.2 ± 7.0 | 26.7 ± 6.7 | 0.894 |
| Diabetes (%) | 33.3 | 16.7 | 33.3 | 0.575 |
| Dialysis duration (min) | 232.5 ± 29.0 | 252.5 ± 27.0 | 232.5 ± 26.0 | 0.134 |
| UFR (mL/h) | 593.4 ± 310.9 | 583.0 ± 332.7 | 624.1 ± 265.3 | 0.943 |
| SysBP (mmHg) | 134.5 ± 14.3 | 140.1 ± 4.5 | 127.1 ± 15.7 | 0.252 |
| ECF (L) | 20.8 ± 2.7 | 20.2 ± 5.1 | 16.8 ± 2.9 | 0.028 |
| FO (L) | 4.8 ± 2.6 | 3.9 ± 2.1 | 2.8 ± 2.8 | 0.182 |
| Body temperature (°C) | 36.1 ± 0.3 | 35.9 ± 0.7 | 36.1 ± 0.3 | 0.376 |
| O2 saturation (%) | 95.9 ± 2.0 | 96.6 ± 2.5 | 96.3 ± 2.6 | 0.789 |
| Plasma Na+ (mmol/L) | 137.9 ± 2.2 | 137.3 ± 2.9 | 138.1 ± 3.8 | 0.130 |
| Plasma K+ (mmol/L) | 4.3 ± 0.8 | 4.4 ± 0.9 | 4.7 ± 0.9 | 0.537 |
| Hct (%) | 30.8 ± 6.4 | 31.6 ± 5.1 | 32.3 ± 5.8 | 0.221 |
| Glucose (mg/dL) | 117.7 ± 30.9 | 123.1 ± 27.8 | 119.5 ± 28.2 | 0.899 |
Bold value is statistically significant (P<0.05).